Levocarnitine recalls
The FDA has published 9 recalls involving Levocarnitine since 2014. The latest was reported on 6 May 2026. Most were for sterility. First Royal Care Co. LLC has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls9since 2014
Last 12 months1reported
Class I00% of total
Ongoing3latest 6 May 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 8 89%Class III 1 11%
Why levocarnitine is recalled
Companies
By year
Ongoing levocarnitine recalls
3 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Levocarnitine Injection, USP (200 mg/mL) Single-Dose Vial recalledLevocarnitine | American Regent | Labeling Errors | Nationwide |
| Drug | CLASS II | Levocarnitine Oral Solution recalled by Akorn | Akorn | Potency & Assay | Nationwide |
| Drug | CLASS II | Levocarnitine 500mg/mL-vial, Refrigerate, Tailor Made Compounding recalled | TMC Acquisition | Sterility | Nationwide |
All levocarnitine recalls, newest first
9 totalShould you stop taking Levocarnitine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.